1. Home
  2. WLDS vs PULM Comparison

WLDS vs PULM Comparison

Compare WLDS & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

N/A

Current Price

$0.73

Market Cap

10.9M

ML Signal

N/A

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$2.05

Market Cap

9.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WLDS
PULM
Founded
2014
2003
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
9.4M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
WLDS
PULM
Price
$0.73
$2.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
119.5K
46.8K
Earning Date
01-01-0001
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
N/A
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5069.93
52 Week Low
$0.45
$1.63
52 Week High
$11.40
$9.37

Technical Indicators

Market Signals
Indicator
WLDS
PULM
Relative Strength Index (RSI) 34.78 37.88
Support Level N/A N/A
Resistance Level $1.06 $5.05
Average True Range (ATR) 0.07 0.27
MACD 0.01 -0.08
Stochastic Oscillator 28.05 23.16

Price Performance

Historical Comparison
WLDS
PULM

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: